Sara Kiflemariam

发表

Expression and Mutation Analyses of Candidate Cancer Genes In Situ

Sara Kiflemariam, 2012 .

In situ detection of individual mRNA molecules and protein complexes or post-translational modifications using padlock probes combined with the in situ proximity ligation assay

Marco Mignardi, I. Grundberg, Sara Kiflemariam, 2013, Nature Protocols.

Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15.

T. Sjöblom, F. Bruzzese, A. Budillon, 2014, Cancer research.

STC1 expression by cancer-associated fibroblasts drives metastasis of colorectal cancer.

T. Sjöblom, K. Jirström, R. Mangues, 2013, Cancer research.

Selective inhibition of proliferation in colorectal carcinoma cell lines expressing mutant APC or activated B‐Raf

A. Burgess, A. Dobrovic, F. Walker, 2009, International journal of cancer.

In situ sequencing identifies TMPRSS2–ERG fusion transcripts, somatic point mutations and gene expression levels in prostate cancers

Muhammad Akhtar Ali, T. Sjöblom, Marco Mignardi, 2014, The Journal of pathology.

In situ mutation detection and visualization of intratumor heterogeneity for cancer research and diagnostics

Mats Nilsson, Marco Mignardi, Johan Botling, 2013, Oncotarget.

VEGF receptor‐2/neuropilin 1 trans‐complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival

C. Lindskog, T. Sjöblom, Sara Kiflemariam, 2018, The Journal of pathology.

Tumor vessel up-regulation of INSR revealed by single-cell expression analysis of the tyrosine kinome and phosphatome in human cancers.

F. Pontén, T. Sjöblom, Sara Kiflemariam, 2015, The American journal of pathology.

Molecular and Cellular Pathobiology Ampli fi cation of FRS 2 andActivation of FGFR / FRS 2 Signaling Pathway in High-Grade Liposarcoma

So, Hanlin Gao, Jinhui Wang, 2013 .

Scalable In Situ Hybridization on Tissue Arrays for Validation of Novel Cancer and Tissue-Specific Biomarkers

F. Pontén, A. Asplund, T. Sjöblom, 2012, PloS one.